We also observed that in COX-2 expressing breast cancer cells, inducible nitric-oxide synthase (iNOS) was upregulated through PGE2/EP4 activity in a cGMP/PKG-dependent manner [107]. The gene discussed is NOS2; the disease is breast carcinoma.